Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04913714 · ClinicalTrials.gov registry record · NA
10+10+30 Infant Vaccines Communication Via Radio in Ethiopia
A NA study of Infant ALL, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 1,320
- Enrollment target
- 2
- Study locations
NCT04913714 is a NA study of Infant ALL that has completed, run by Syracuse University. The registered enrollment target is 1,320 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04913714, a NA study of Infant ALL, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,320 participants
- Enrollment target
- 2
- Study locations
Study Summary
A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness
Conditions Studied
Interventions
- BEHAVIORAL 3-month radio intervention on infant vaccination
Study Locations (2)
New York
- Syracuse University - Syracuse
Other
- Jimma University - Jimma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,320 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2021-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04913714
The ClinicalTrials.gov registry entry for NCT04913714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infant ALL appearing as the primary indexed condition, and to 1 intervention - of which 3-month radio intervention on infant vaccination is the first listed.
NCT04913714 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Other.
Frequently Asked Questions
What is clinical trial NCT04913714 about?
NCT04913714 is a clinical study titled "10+10+30 Infant Vaccines Communication Via Radio in Ethiopia". A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness
What is the current status of trial NCT04913714?
This trial is currently completed. It is a NA study. The enrollment target is 1,320 participants. The study started on 2020-10-13. Estimated completion is 2021-01-31.
What conditions does trial NCT04913714 study?
This clinical trial studies the following conditions: Infant ALL.
What interventions are being tested in trial NCT04913714?
The interventions under investigation include: 3-month radio intervention on infant vaccination (BEHAVIORAL).
Who is sponsoring clinical trial NCT04913714?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04913714 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.